Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.38 USD | +0.38% | +2.07% | -31.29% |
Jun. 04 | Amphastar Pharmaceuticals, Inc. Approves the Appointment of Howard Lee as Director | CI |
Jun. 04 | Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.29% | 2.06B | |
+43.25% | 750B | |
+34.11% | 606B | |
-6.82% | 356B | |
+19.01% | 326B | |
+6.75% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+1.89% | 167B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- JPMorgan Initiates Amphastar Pharmaceuticals With Overweight Rating, Price Target is $60